Below is a compiled list of scientific research and studies on Cannabidiol (CBD) and it’s potential use for treating Inflammation.
- Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
- Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice.
- Cannabinoids, endocannabinoids, and related analogs in inflammation.
- The endocannabinoid system: an emerging key player in inflammation
- Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: role for the adenosine A(2A) receptor.
- Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.
- Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation.
- Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis.
- Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.
- Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death.
- Cannabinoids, inflammation, and fibrosis.
- Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis.
- Protective effect of cannabidiol on hydrogen peroxide‑induced apoptosis, inflammation and oxidative stress in nucleus pulposus cells.
- Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain.
- Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
